JoshuaHillMD
Infectious Disease • Seattle, WAClinical Fellow in Medicine, Brigham and Women's Hospital
Dr. Hill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 617-496-5804
Education & Training
University of WashingtonFellowship, Infectious Disease, 2012 - 2015
UMass Chan Medical SchoolResidency, Surgery, 2002 - 2010
University of Texas Southwestern Medical SchoolClass of 2009
Certifications & Licensure
MT State Medical License 2022 - 2026
WA State Medical License 2012 - 2026
MA State Medical License 2011 - 2012
Clinical Trials
- A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy Start of enrollment: 2021 Apr 28
Roles: Contact
- Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19 Start of enrollment: 2021 Aug 01
Roles: Contact, Principal Investigator
- Vaccine Responsiveness After CAR-T Cell Therapy Start of enrollment: 2020 Aug 03
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 7 citationsConsistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study.Samuel M Brown, Morgan J Katz, Adit A Ginde, Kavita Juneja, Monica Ramchandani
Infectious Diseases and Therapy. 2023-04-01 - 13 citationsUnbiased optical mapping of telomere-integrated endogenous human herpesvirus 6.Darren J. Wight, Giulia Aimola, Amr Aswad, Chi-Yu Jill Lai, Christian Bahamon
Proceedings of the National Academy of Sciences of the United States of America. 2020-12-08 - 29 citationsIncidence, Risk Factors, and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell TransplantationDavid S. Wenger, Matthew Triplette, Kristina Crothers, Guang-Shing Cheng, Joshua A. Hill
Biology of Blood and Marrow Transplantation. 2019-10-09
Press Mentions
Infectious Disease Experts Propose Trials Network Dedicated to Immunocompromised PatientsOctober 24th, 2024- What Does It Mean to Be Immunocompromised?October 10th, 2024
- National Study Recommends Starting SARS-CoV-2 mRNA Vaccination Three Months After Bone Marrow TransplantMay 16th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
